Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,570
-10 (-0.09%)
Last updated: Dec 5, 2025, 10:52 AM KST

Whan In Pharm Revenue

Whan In Pharm had revenue of 65.74B KRW in the quarter ending September 30, 2025, a decrease of -3.49%. This brings the company's revenue in the last twelve months to 256.32B, up 1.83% year-over-year. In the year 2024, Whan In Pharm had annual revenue of 259.60B with 12.68% growth.

Revenue (ttm)
256.32B
Revenue Growth
+1.83%
P/S Ratio
0.69
Revenue / Employee
426.49M
Employees
601
Market Cap
177.25B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024259.60B29.20B12.68%
Dec 31, 2023230.39B31.46B15.81%
Dec 31, 2022198.93B21.16B11.90%
Dec 31, 2021177.78B6.07B3.54%
Dec 31, 2020171.71B12.53B7.87%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2012 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro
Dec 31, 2010 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 5,504.84B
Celltrion 3,895.99B
ALTEOGEN 202.18B
ABL Bio 88.44B
SK Biopharmaceuticals 675.41B
Yuhan 2,136.67B
LigaChem Biosciences 159.27B
Peptron 6.19B
Revenue Rankings